open access

Vol 23, No 2 (2020)
Clinical vignette
Published online: 2020-07-31
Submitted: 2020-02-20
Accepted: 2020-07-08
Get Citation

Primary skeletal muscle lymphoma with unusual soft tissue metastases in the stomach and pancreas detected by 18F-FDG PET/CT

Fatemeh Farahmandfar, Sara Shakeri, Sadegh Moradian, Shirin Shahlaei, Ramin Sadeghi
DOI: 10.5603/NMR.2020.0021
·
Nucl. Med. Rev 2020;23(2):102-103.

open access

Vol 23, No 2 (2020)
Clinical vignette
Published online: 2020-07-31
Submitted: 2020-02-20
Accepted: 2020-07-08

Abstract

A 69 y/o woman with a history of primary diffuse large B cell lymphoma in the right thigh muscle was referred for recurrence evaluation with 18F-FDG PET/CT. After routine courses of chemoradiation, MRI was done in order to evaluate treatment response with inconclusive findings. 18FDG PET/CT revealed abnormal uptake in the primary site of the disease as well as secondary involvement of stomach, pancreas, pelvic lymph nodes, and both tibiae. Our case showed the importance of 18F-FDG PET/CT in the detection of unusual soft tissue extension of lymphoma.

Abstract

A 69 y/o woman with a history of primary diffuse large B cell lymphoma in the right thigh muscle was referred for recurrence evaluation with 18F-FDG PET/CT. After routine courses of chemoradiation, MRI was done in order to evaluate treatment response with inconclusive findings. 18FDG PET/CT revealed abnormal uptake in the primary site of the disease as well as secondary involvement of stomach, pancreas, pelvic lymph nodes, and both tibiae. Our case showed the importance of 18F-FDG PET/CT in the detection of unusual soft tissue extension of lymphoma.

Get Citation

Keywords

Diffuse large B-cell lymphoma; non-Hodgkin’s lymphoma; 18F-FDG PET/CT

About this article
Title

Primary skeletal muscle lymphoma with unusual soft tissue metastases in the stomach and pancreas detected by 18F-FDG PET/CT

Journal

Nuclear Medicine Review

Issue

Vol 23, No 2 (2020)

Pages

102-103

Published online

2020-07-31

DOI

10.5603/NMR.2020.0021

Bibliographic record

Nucl. Med. Rev 2020;23(2):102-103.

Keywords

Diffuse large B-cell lymphoma
non-Hodgkin’s lymphoma
18F-FDG PET/CT

Authors

Fatemeh Farahmandfar
Sara Shakeri
Sadegh Moradian
Shirin Shahlaei
Ramin Sadeghi

References (11)
  1. Fujikawa T, Kawachi Y. Diffuse large B-cell lymphoma in the psoas muscle. BMJ Case Rep. 2015; 2015.
  2. Bourdeanu L, Menon R, Somlo G. Diffuse large B-cell lymphoma with calf muscle localization. Case Rep Hematol. 2011; 2011: 292494.
  3. Zhang L, Lin Q, Zhang L, et al. Primary skeletal muscle diffuse large B cell lymphoma: A case report and review of the literature. Oncol Lett. 2015; 10(4): 2156–2160.
  4. Surov A, Surov A, Behrmann C. Diffusion-weighted imaging of skeletal muscle lymphoma. Skeletal Radiol. 2014; 43(7): 899–903.
  5. Lehners N, Krämer I, Saadati M, et al. Analysis of clinical characteristics and outcome of patients with previously untreated diffuse large B-cell lymphoma and renal involvement in the rituximab era. Leuk Lymphoma. 2016; 57(11): 2619–2625.
  6. Saif MW, Khubchandani S, Walczak M. Secondary pancreatic involvement by a diffuse large B-cell lymphoma presenting as acute pancreatitis. World J Gastroenterol. 2007; 13(36): 4909–4911.
  7. Alekshun TJ, Rezania D, Ayala E, et al. Skeletal muscle peripheral T-cell lymphoma. J Clin Oncol. 2008; 26(3): 501–503.
  8. Sin KM, Ho SK, Wong BY, et al. Beyond the lymph nodes: FDG-PET/CT in primary extranodal lymphoma. Clin Imaging. 2017; 42: 25–33.
  9. Ding JJ, Chen YL, Zhou SH, et al. Positron emission tomography/computed tomography in the diagnosis, staging, and prognostic evaluation of natural killer/T-cell lymphoma. J Int Med Res. 2018; 46(12): 4920–4929.
  10. Gallamini A, Zwarthoed C, Borra A. Positron Emission Tomography (PET) in Oncology. Cancers (Basel). 2014; 6(4): 1821–1889.
  11. Hutchings M, Loft A, Hansen M, et al. Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma. Haematologica. 2006; 91(4): 482–489.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl